Strategic Partnerships AVACEN Medical has recently formed a partnership with BrainIQ Health to enhance smarter wellness solutions, presenting an opportunity to co-market with allied health and wellness platforms, expand channel partnerships, and access new customer bases in integrative health spaces.

Executive Leadership Appointment of co-founder Danielle Forsgren as President signals strategic leadership focus and potential expansions in sales, marketing, and distribution. This presents a chance to engage at the executive level for larger deals, pilots, or regional scaling efforts.

Market Expansion CE Mark approval for fibromyalgia and FDA clearance for the AVACEN 100 indicate regulatory validation and readiness for EU and US markets. Target healthcare providers, pain clinics, and rehabilitation centers seeking noninvasive, drug-free pain management solutions.

Social Impact Fire Relief Fund initiative demonstrates a strong corporate social responsibility signal, which can be leveraged to open conversations with public sector, first responder programs, and charitable health initiatives for device funding partnerships or grant-supported pilots.

Strategic Fit The AVACEN 100’s noninvasive heat therapy with a broad mechanism of action aligns with markets seeking complementary therapies for circulatory, neurological, lymphatic, and endocrinal concerns. This positions AVACEN as a candidate for bundled pain management solutions with clinics and medical device distributors seeking diversified portfolios.